Clover Biopharmaceuticals, Ltd. (CBPHF) Form 10-Q Quarterly Reports
Access SEC EDGAR filings, financial statements, 10-K, 10-Q, 8-K reports, auditor information, and financial intelligence for Clover Biopharmaceuticals, Ltd. (CBPHF).
Ticker: CBPHF
CIK: 1856491
Exchange: OTC
Fiscal Year End: 12/31
State: E9
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PCAOB Registered Accounting Firm
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| D | 2026-04-29 | — | D Filing | 0001856491-26-000003 | View SEC Doc Filr Page |
| D/A | 2025-04-28 | — | D/A Filing | 0001856491-25-000001 | View SEC Doc Filr Page |
| D | 2024-04-12 | — | D Filing | 0001856491-24-000005 | View SEC Doc Filr Page |
| D/A | 2023-05-09 | — | D/A Filing | 0001104659-23-057396 | View SEC Doc Filr Page |
| D/A | 2022-05-24 | — | D/A Filing | 0001104659-22-064094 | View SEC Doc Filr Page |
| D | 2021-04-28 | — | D Filing | 0001104659-21-056432 | View SEC Doc Filr Page |